Expertise in
2
conditions

Mette S. Holm

Palle Juul Jensens Boulevard 99, 
Arhus, DK 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
2
conditions
Palle Juul Jensens Boulevard 99, 
Arhus, DK 

Overview

Mette Holm practices in Arhus, Denmark. Ms. Holm is highly rated in 2 conditions, according to our data. Her top areas of expertise are Myelodysplastic Syndrome (MDS), Multisystem Inflammatory Syndrome in Children (MIS-C), Septic Arthritis, and Pediatric Myocarditis.

Her clinical research consists of co-authoring 70 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Gender

Female

Locations

Palle Juul Jensens Boulevard 99, Arhus, 8200, Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) With Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)
ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) With Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)
Enrollment Status: Recruiting
Publish Date: March 27, 2026
Intervention Type: Drug
Study Drugs: Doxorubicin, Vincristine, Dexamethasone, Inotuzumab, Imatinib, 6-Tioguanine, Blinatumomab
Study Phase: Phase 3

70 Total Publications

Procalcitonin compared to C-reactive protein and leukocyte count. A comparative analysis of baseline markers of bacterial co-infection in patients admitted with a viral respiratory tract infection. A retrospective observational cohort study.
Procalcitonin compared to C-reactive protein and leukocyte count. A comparative analysis of baseline markers of bacterial co-infection in patients admitted with a viral respiratory tract infection. A retrospective observational cohort study.
Journal: Infectious diseases (London, England)
Published: March 03, 2026

Frequently Asked Questions about Mette S. Holm

Is Mette S. Holm a top-rated expert for Myelodysplastic Syndrome (MDS)?

MediFind is an objective health platform that identifies experts based on real-world data. Mette S. Holm is classified as an Advanced expert for Myelodysplastic Syndrome (MDS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Mette S. Holm participate in research or clinical trials?

Yes. Mette S. Holm has published 70 articles and abstracts on conditions like Myelodysplastic Syndrome (MDS). You can view a list of Mette S. Holm's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Holm's expertise for a condition
ConditionClose
      View All 37 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile